Asthma Flashcards

(16 cards)

1
Q

A clinical syndrome characterized by airway obstruction, which is partially or completely reversible either spontaneously or with treatment. Characteristics include ________ and
________ to various stimuli.

A

airway inflammation, airway hyperresponsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

B. Causes

  1. The exact underlying cause remains_____
  2. The cause is associated with the following:
A

unknown

a. Allergic response
b. Heredity
c. Environmental factors
d. Infection
e. Psychosocial factors
f. Socioeconomic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classifications of Asthma (based on the National

Asthma Education and Prevention Program, or NAEPP)

A

Intermittent, Mild persistent, Moderate persistent and severe persistent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intermittent

a. This is the least _______ of the four classifications.
b. Symptoms of wheezing or coughing are experienced ______
c. The patients in this category generally have FEV1 and peak expiratory flow (PEF) values of _______ of predicted.
d. Routine management generally consists of ______, as needed.
e. Exacerbation of symptoms rarely results in emergency department treatment or hospitalization. T/F

A

severe, no more than twice per week, at least 80%, beta-2 agonists (SABAs), T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Mild persistent
    a. Symptoms of coughing or wheezing are experienced _________ but less than ______
    b. Symptoms affect the patient’s daily activity and sleep during the night; nocturnal coughing, wheezing, or dyspnea is experienced ________.
    c. The patients in this category generally have FEV1 and PEF values of ________ of predicted.
    d. Routine management generally consists of ______ to control symptoms and the use of a _______, as needed.
    e. Emergency department treatment for exacerbations occurs _______ and may occasionally result in hospitalization.
A

more than twice per week, once per day, more than twice per month, at least 80%, ICS therapy, SABA, periodically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Moderate persistent

a. Symptoms of coughing or wheezing are experienced______in this category.
b. Exacerbation of symptoms are experienced _______ and may persist for several days. Symptoms affect the patient’s daily activity and sleep during the night; nocturnal coughing, wheezing, or dyspnea is experienced _________.
d. The patients in this category generally have FEV1 and PEF values of 60% to 80% of predicted.
e. Daily management generally consists of a SABA as needed for symptoms and not to exceed ______; _____ for nocturnal symptoms; ____ daily.
f. Patients in this category routinely _____ emergency department treatment or require hospitalization.

A

almost daily, at least twice per week, more than once per week, 60% to 80%, SABA, 3 to 4 times per day, LABA, ICS, require

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

. Severe persistent

a. This is the ______ category of the four. Symptoms of coughing or wheezing are experienced ______.
b. Exacerbations are ______ and may last for weeks.
c. Symptoms affect the patient’s daily activity and sleep during the night; nocturnal coughing, wheezing, or dyspnea is experienced ______.
d. The patients in this category generally have FEV1 and PEF values of ______ of predicted.
e. Daily management generally consists of a _____ as needed for symptoms, not to exceed ______; ________ for nocturnal symptoms and frequent exacerbations; ______ daily.
f. Patients in this category routinely require emergency department treatment or require hospitalization.

A

worst, almost continually, frequent, almost every night, 60% or less, SABA, 3 to 4 times per day, LABA and oral corticosteroids, ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathophysiology

  1. When the asthmatic inhales an allergen that he or she is sensitive to, mast cells located in the bronchial mucosa and submucosa release the following chemical mediators:
  2. The release of these substances results in:
A

a. Histamine
b. Leukotrienes
c. Platelet-activating factor
d. Prostaglandins

a. Bronchoconstriction
b. Mucosal edema
c. Increased mucus production
d. Accumulation of eosinophils in the blood and
sputum
e. Inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical Signs and Symptoms
1. Mild ______ and _____ initially, which may
progress to severe dyspnea if the attack is not reversed.
2. The cough is initially _______, progressing to a ______ cough by the end of the episode.
3. Secretions contain high levels of ______.
4. ________ retractions.
5. The use of _______ to breathe (in a
severe attack).
6. Paradoxical pulse: systolic blood pressure is ______
higher on _______.
7. Tachycardia and tachypnea
8. ABG levels initially reveal _______. PaCO2 increases as the attack worsen and the patient begins to tire.

A

wheezing, coughing, nonproductive, productive, eosinophils, Intercostal and supraclavicular, accessory muscles, 10 mm Hg, expiration than on inspiration, hypoxemia and low PaCO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Characteristics of Chest X-ray

A
  1. Hyperinflation (hyperlucency of lung fields)
  2. Atelectasis
  3. Infiltrates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of Pulmonary Function Studies

A
  1. Decreased FEV1
  2. Decreased FVC
  3. Decreased FEV1/FVC
  4. Increased RV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Asthma Preventative Drugs
1. _________: mast cell stabilizer referred
to as a noncorticosteroid antiinflammatory drug
2. _________: zafirlukast (Accolate) or
montelukast (Singulair)
3. Covered in detail in Chapter 14, Respiratory
Medications

A

Cromolyn sodium (Intal), Leukotriene modifiers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment (During an Attack)

A
  1. Rescue SABAs such as albuterol or Xopenex
  2. IV fluids
  3. O2 therapy
  4. IV corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a severe asthmatic attack that responds poorly to bronchodilator therapy and is associated with signs or symptoms of potential respiratory failure

A

Status Asthmaticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nocturnal Asthma
1. Nocturnal (nighttime) symptoms are seen in up to
____ of all patients with asthma and even in those
who have mild intermittent or mild persistent
asthma.
2. Mechanisms resulting in nocturnal symptoms may
be related to changes in ___________
3. Other causes may include aspiration, sleep apnea, increased mucus production, sinusitis, gastroesophageal reflux, and a normal decrease in lung function when the patient is sleeping.
4. First line management is_____. May also be managed
by _____

A

75%, agal tone, body temperature, mediators, epinephrine, inflammation, and b2-receptor function during sleep, ICS, LABA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Occupational Asthma
1. Characterized by increased _______
while at work or within several hours after leaving
work and improving on days off from work.
2. Diagnosis may be made by measuring _______.
3. The most common workplace causes include
_______

A

wheezing or coughing, peak flows while at work, formaldehyde, grain dust, cigarette smoke, and avian proteins